Surgeon Experience ReSTOR A +4 Intraocular Lens (IOL)

NCT00733512 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 146

Last updated 2017-03-27

Study results available
· View outcomes & findings →

Summary

To collect visual outcome data post AcrySof ReSTOR Aspheric +4 implantation from surgeons throughout the United States.

Conditions

  • Cataract

Interventions

DEVICE

ReSTOR

Patients were implanted with the AcrySof ReSTOR Aspheric +4 Intraocular Lens (IOL) in one or both eyes for treatment of cataract.

Sponsors & Collaborators

  • Alcon Research

    lead INDUSTRY

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-06-30
Primary Completion
2008-03-31
Completion
2008-03-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00733512 on ClinicalTrials.gov